Small-molecule screening identifies modulators of aquaporin-2 trafficking

Journal of the American Society of Nephrology

Volumn 24, Issue 5, 2013, Pages 744-758

  Bogum, Jana ^a,b,c   Faust, Dörte ^a   Zuḧlke, Kerstin ^a,b   Eichhorst, Jenny ^b   Moutty, Marie C ^a,b   Furkert, Jens ^b   Eldahshan, Adeeb ^a   Neuenschwander, Martin ^b   Von Kries, Jens Peter ^b   Wiesner, Burkhard ^b   Trimpert, Christiane ^d   Deen, Peter M T ^d   Valenti, Giovanna ^e   Rosenthal, Walter ^a,f   Klussmann, Enno ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF BARI   (Italy)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETYLDIPHYLLIN; AQUAPORIN 2; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FLUCONAZOLE; FORSKOLIN; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; SERINE DERIVATIVE; SMALL MOLECULE TRANSPORT AGENT; UNCLASSIFIED DRUG;

ARTICLE; AUTOMATION; BIOTINYLATION; CELL ASSAY; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CELL MIGRATION; CELL SURFACE; CELL VACUOLE; DRUG SCREENING; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; GOLGI COMPLEX; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY COLLECTING TUBULE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WATER ABSORPTION; WESTERN BLOTTING;

EID: 84877099711     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012030295     Document Type: Article

References (54)

1. Nedvetsky PI, Tamma G, Beulshausen S, Valenti G, Rosenthal W, Klussmann E: Regulation of aquaporin-2 trafficking. Handb Exp Pharmacol: 133-157, 2009
2. Brown D, Bouley R, Pǎunescu TG, Breton S, Lu HA: New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells. Am J Physiol Cell Physiol 302: C1421-C1433, 2012
3. Deen PM, Knoers NV: Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus. Am J Med Sci 316: 300-309, 1998 (Pubitemid 28525027)
4. Bichet DG, Oksche A, Rosenthal W: Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 8: 1951-1958, 1997 (Pubitemid 28185455)
5. Wesche D, Deen PM, Knoers NV: Congenital nephrogenic diabetes insipidus: The current state of affairs. Pediatr Nephrol 27: 2183-2204, 2012
6. Schrier RW: Use of diuretics in heart failure and cirrhosis. Semin Nephrol 31: 503-512, 2011
7. Katsura T, Gustafson CE, Ausiello DA, Brown D: Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells. Am J Physiol 272: F817-F822, 1997
8. Fushimi K, Sasaki S, Marumo F: Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem 272: 14800-14804, 1997 (Pubitemid 27251748)
9. van Balkom BW, Savelkoul PJ, Markovich D, Hofman E, Nielsen S, van der Sluijs P, Deen PM: The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel. J Biol Chem 277: 41473- 41479, 2002
10. Kuwahara M, Asai T, Terada Y, Sasaki S: The C-terminal tail of aquaporin-2 determines apical trafficking. Kidney Int 68: 1999-2009, 2005 (Pubitemid 43117775)
11. Klussmann E, Maric K, Wiesner B, Beyermann M, Rosenthal W: Protein kinase A anchoring proteins are required for vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J Biol Chem 274: 4934-4938, 1999
12. Hoffert JD, Pisitkun T, Wang G, Shen RF, Knepper MA: Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites. Proc Natl Acad Sci U S A 103: 7159-7164, 2006
13. Fenton RA, Moeller HB, Hoffert JD, Yu MJ, Nielsen S, Knepper MA: Acute regulation of aquaporin-2 phosphorylation at Ser-264 by vasopressin. Proc Natl Acad Sci U S A 105: 3134-3139, 2008 (Pubitemid 351723680)
14. Moeller HB, Praetorius J, Rützler MR, Fenton RA: Phosphorylation of aquaporin-2 regulates its endocytosis and protein-protein interactions. Proc Natl Acad Sci U S A 107: 424-429, 2010
15. Hoffert JD, Fenton RA, Moeller HB, Simons B, Tchapyjnikov D, McDill BW, Yu MJ, Pisitkun T, Chen F, Knepper MA: Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2. J Biol Chem 283: 24617-24627, 2008
16. Moeller HB, Knepper MA, Fenton RA: Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells. Kidney Int 75: 295-303, 2009
17. Rice WL, Zhang Y, Chen Y, Matsuzaki T, Brown D, Lu HA: Differential, phosphorylation dependent trafficking of AQP2 in LLC-PK1 cells. PLoS ONE 7: e32843, 2012
18. Tamma G, Robben JH, Trimpert C, Boone M, Deen PM: Regulation of AQP2 localization by S256 and S261 phosphorylation and ubiquitination. Am J Physiol Cell Physiol 300: C636-C646, 2011
19. Nedvetsky PI, Tabor V, Tamma G, Beulshausen S, Skroblin P, Kirschner A, Mutig K, Boltzen M, Petrucci O, Vossenkämper A, Wiesner B, Bachmann S, Rosenthal W, Klussmann E: Reciprocal regulation of aquaporin-2 abundance and degradation by protein kinase A and p38-MAP kinase. J Am Soc Nephrol 21: 1645-1656, 2010
20. Iolascon A, Aglio V, Tamma G, D'Apolito M, Addabbo F, Procino G, Simonetti MC, Montini G, Gesualdo L, Debler EW, Svelto M, Valenti G: Characterization of two novel missense mutations in the AQP2 gene causing nephrogenic diabetes insipidus. Nephron Physiol 105: p33-41, 2007
21. Choi M, Eulenberg C, Rolle S, von Kries JP, Luft FC, Kettritz R: The use of small molecule high-throughput screening to identify inhibitors of the proteinase 3-NB1 interaction. Clin Exp Immunol 161: 389-396, 2010
22. Stefan E, Wiesner B, Baillie GS, Mollajew R, Henn V, Lorenz D, Furkert J, Santamaria K, Nedvetsky P, Hundsrucker C, Beyermann M, Krause E, Pohl P, Gall I, MacIntyre AN, Bachmann S, Houslay MD, Rosenthal W, Klussmann E: Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells. J Am Soc Nephrol 18: 199-212, 2007 (Pubitemid 46053433)
23. Murray AJ: Pharmacological PKA inhibition: All may not be what it seems. Sci Signal 1: re4, 2008
24. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000
25. Trimpert C, van den Berg DT, Fenton RA, Klussmann E, Deen PM: Vasopressin increases S261 phosphorylation in AQP2-P262L, a mutant in recessive nephrogenic diabetes insipidus. Nephrol Dial Transplant 27: 4389-4397, 2012
26. Sørensen MG, Henriksen K, Neutzsky-Wulff AV, Dziegiel MH, Karsdal MA: Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption. J Bone Miner Res 22: 1640-1648, 2007 (Pubitemid 351229334)
27. Clague MJ, Urbé S, Aniento F, Gruenberg J: Vacuolar ATPase activity is required for endosomal carrier vesicle formation. J Biol Chem 269: 21-24, 1994 (Pubitemid 24026612)
28. Bowman EJ, Siebers A, Altendorf K: Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 85: 7972-7976, 1988
29. Brown D, Breton S, Ausiello DA, Marshansky V: Sensing, signaling and sorting events in kidney epithelial cell physiology. Traffic 10: 275-284, 2009
30. Gustafson CE, Katsura T, McKee M, Bouley R, Casanova JE, Brown D: Recycling of AQP2 occurs through a temperature- and bafilomycin-sensitive trans-Golgi-associated compartment. Am J Physiol Renal Physiol 278: F317-F326, 2000 (Pubitemid 30131285)
31. Moriyama Y, Nelson N: H+-translocating ATPase in Golgi apparatus. Characterization as vacuolar H+-ATPase and its subunit structures. J Biol Chem 264: 18445-18450, 1989 (Pubitemid 19277587)
32. Lepesheva GI, Waterman MR: Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis. Curr Top Med Chem 11: 2060-2071, 2011
33. Niwa T, Shiraga T, Takagi A: Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull 28: 1805-1808, 2005 (Pubitemid 41324160)
34. Henn V, Edemir B, Stefan E, Wiesner B, Lorenz D, Theilig F, Schmitt R, Vossebein L, Tamma G, Beyermann M, Krause E, Herberg FW, Valenti G, Bachmann S, Rosenthal W, Klussmann E: Identification of a novel Akinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cells. J Biol Chem 279: 26654-26665, 2004 (Pubitemid 38798823)
35. Okutsu R, Rai T, Kikuchi A, Ohno M, Uchida K, Sasaki S, Uchida S: AKAP220 colocalizes with AQP2 in the inner medullary collecting ducts. Kidney Int 74: 1429-1433, 2008
36. Skroblin P, Grossmann S, Schäfer G, Rosenthal W, Klussmann E: Mechanisms of protein kinase A anchoring. Int Rev Cell Mol Biol 283: 235-330, 2010
37. Horner A, Goetz F, Tampé R, Klussmann E, Pohl P: Mechanism for targeting the A-kinase anchoring protein AKAP18δ to the membrane. J Biol Chem 287: 42495-42501, 2012
38. Troger J, Moutty MC, Skroblin P, Klussmann E: A-kinase anchoring proteins as potential drug targets. Br J Pharmacol 166: 420-433, 2012
39. Hundsrucker C, Skroblin P, Christian F, Zenn HM, Popara V, Joshi M, Eichhorst J, Wiesner B, Herberg FW, Reif B, Rosenthal W, Klussmann E: Glycogen synthase kinase 3beta interaction protein functions as an A-kinase anchoring protein. J Biol Chem 285: 5507-5521, 2010
40. Hurtado-Lorenzo A, Skinner M, El Annan J, Futai M, Sun-Wada GH, Bourgoin S, Casanova J, Wildeman A, Bechoua S, Ausiello DA, Brown D, Marshansky V: V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat Cell Biol 8: 124-136, 2006
41. Bjarnadottir U, Nielsen JE: Calculating pKa values in the cAMP-dependent protein kinase: The effect of conformational change and ligand binding. Protein Sci 19: 2485-2497, 2010
42. Carrey EA: A protonated histidine residue in a phosphorylation site for cyclic AMP-dependent protein kinase. Comparison of a synthetic peptide with the exposed linking region in the multienzyme polypeptide CAD. Biochem J 287: 791-795, 1992
43. Nedvetsky PI, Stefan E, Frische S, Santamaria K, Wiesner B, Valenti G, Hammer JA 3rd, Nielsen S, Goldenring JR, Rosenthal W, Klussmann E: A Role of myosin Vb and Rab11-FIP2 in the aquaporin-2 shuttle. Traffic 8: 110-123, 2007 (Pubitemid 46099998)
44. Procino G, Carmosino M, Marin O, Brunati AM, Contri A, Pinna LA, Mannucci R, Nielsen S, Kwon TH, Svelto M, Valenti G: Ser-256 phosphorylation dynamics of Aquaporin 2 during maturation from the ER to the vesicular compartment in renal cells. FASEB J 17: 1886-1888, 2003
45. Brown D, Hasler U, Nunes P, Bouley R, Lu HA: Phosphorylation events and the modulation of aquaporin 2 cell surface expression. Curr Opin Nephrol Hypertens 17: 491-498, 2008
46. Teplova VV, Tonshin AA, Grigoriev PA, Saris NE, Salkinoja-Salonen MS: Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions. J Bioenerg Biomembr 39: 321-329, 2007 (Pubitemid 350029431)
47. Ohta T, Arakawa H, Futagami F, Fushida S, Kitagawa H, Kayahara M, Nagakawa T, Miwa K, Kurashima K, Numata M, Kitamura Y, Terada T, Ohkuma S: Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1. J Pathol 185: 324-330, 1998 (Pubitemid 28320056)
48. Okahashi N, Nakamura I, Jimi E, Koide M, Suda T, Nishihara T: Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts. J Bone Miner Res 12: 1116-1123, 1997 (Pubitemid 27264226)
49. Pérez-Sayáns M, Somoza-Martín JM, Barros-Angueira F, Rey JM, García-García A: V-ATPase inhibitors and implication in cancer treatment. Cancer Treat Rev 35: 707-713, 2009
50. Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A: Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 25: 343-346, 2000 (Pubitemid 30437326)
51. Maric K, Oksche A, Rosenthal W: Aquaporin-2 expression in primary cultured rat inner medullary collecting duct cells. Am J Physiol 275: F796-F801, 1998
52. Klussmann E, Tamma G, Lorenz D, Wiesner B, Maric K, Hofmann F, Aktories K, Valenti G, Rosenthal W: An inhibitory role of Rho in the vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J Biol Chem 276: 20451-20457, 2001
53. Haas AK, Kleinau G, Hoyer I, Neumann S, Furkert J, Rutz C, Schülein R, Gershengorn MC, Krause G: Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor. Cell Mol Life Sci 68: 159-167, 2011
54. Christian F, Szaszák M, Friedl S, Drewianka S, Lorenz D, Goncalves A, Furkert J, Vargas C, Schmieder P, Götz F, Zühlke K, Moutty M, Göttert H, Joshi M, Reif B, Haase H, Morano I, Grossmann S, Klukovits A, Verli J, Gáspár R, Noack C, Bergmann M, Kass R, Hampel K, Kashin D, Genieser HG, Herberg FW, Willoughby D, Cooper DM, Baillie GS, Houslay MD, von Kries JP, Zimmermann B, Rosenthal W, Klussmann E: Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J Biol Chem 286: 9079-9096, 2011